Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
Study NCT ID:
NCT04465266
Status:
COMPLETED
Last Update Posted:
2022-02-01
First Post:
2020-07-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 PK Study of Tolperisone in Healthy Subjects
Sponsor:
Neurana Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-02
First Submit QC Date:
None
Study First Post Date:
2020-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-28
Last Update Post Date:
2022-02-01
Last Update Post Date Type:
ACTUAL